Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine versus bupivacaine plus dexmedetomidine for post-cesarean pain
IRCT20200825048515N60Phase 2Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in postoperative pain comparing Bupivacaine with Bupivacaine + dexmedetomidine (2 arms). Primary endpoints: Pain intensity, Blood pressure and 3 more. Started Sep 2022; status: completed.
02
Drugs
bupivacainedexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20200825048515N60.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200825048515N60.